September 14, 2010
Global Network for Women’s and Children’s Health Research, NICHD
Dale and Betty Bumpers Vaccine Research Center - Building 49, Room 1A51/1A59, NIH Main Campus, Bethesda, Maryland
Since the last studies on the burden of human monkeypox in the DRC were conducted 1986, the population that is immunologically naïve to orthopoxviruses has increased significantly due to cessation of mass smallpox vaccination campaigns. Anne W. Rimoin, Ph.D., M.P.H., an assistant professor in the Department of Epidemiology at the University of California, Los Angeles, School of Public Health conducted studies to assess the current risk of infection of monkeypox, and made some exciting findings. Among them, her research showed that 30 years after mass smallpox vaccination campaigns stopped, the incidence of human monkeypox has dramatically increased in the DRC. This finding has far-reaching public health implications and could impact future vaccination campaigns in the DRC and similar areas. Dr. Rimoin, who has received funding for this and other research from the NICHD, the National Institute of Allergy and Infectious Diseases, Fogarty International Center, the NIH Office of AIDS Research, and the National Center for Research Resources, will discuss her research and her findings during this hour-long seminar.
Dr. Linda Wright, Global Network for Women’s and Children’s Health Research, NICHDTel: (301) 402-0830E-mail: email@example.com